MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway

Brain microvascular endothelial cells (BMECs) dysfunction is related to the pathogenesis of neurovascular complication of diabetes mellitus that adversely lead to various CNS disorders. Mitoquinone (MitoQ) is a mitochondria targeted antioxidant that exerts multiple protective effects in many oxidati...

Full description

Saved in:
Bibliographic Details
Main Authors: Min-yan Yang (Author), Zhen Fan (Author), Zhao Zhang (Author), Jin Fan (Author)
Format: Book
Published: Elsevier, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_25c25d24eb614c8082e1f05f6b0251ad
042 |a dc 
100 1 0 |a Min-yan Yang  |e author 
700 1 0 |a Zhen Fan  |e author 
700 1 0 |a Zhao Zhang  |e author 
700 1 0 |a Jin Fan  |e author 
245 0 0 |a MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway 
260 |b Elsevier,   |c 2021-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2020.10.007 
520 |a Brain microvascular endothelial cells (BMECs) dysfunction is related to the pathogenesis of neurovascular complication of diabetes mellitus that adversely lead to various CNS disorders. Mitoquinone (MitoQ) is a mitochondria targeted antioxidant that exerts multiple protective effects in many oxidative damage-related diseases. In this study, we determined the protective effects of MitoQ on high glucose (HG)-induced BMECs injury and investigated the underlying mechanism. We found that HG significantly reduced the expression of Nrf2 and HO-1, decreased mitochondrial membrane potential, increased intracellular and mitochondrial reactive oxygen species (ROS) generation, induced cytoskeletal damage and apoptosis in BMECs. In addition, Mito tempol, a mitochondrial ROS scavenger, significantly reduced HG-induced mitochondrial ROS production and attenuated cytoskeletal damage and cell apoptosis, suggesting MtROS production was involved in HG-induced BMECs injury. Moreover, we found that MitoQ treatment significantly upregulated the expression of Nrf2 and HO-1 in HG-induced BMECs, which is accompanied by improved mitochondrial membrane potential and decreased MtROS production. Meanwhile, MitoQ treatment also remarkably attenuated HG-induced cytoskeletal damage and cell apoptosis in BMECs. However, inhibitor of Nrf2 with ML385 impaired the protective effects of MitoQ in HG-induced BMECs. In conclusion, our results suggest that MitoQ exerts protective effect on HG-induced BMECs injury via activating Nrf2/HO-1 pathway. 
546 |a EN 
690 |a MitoQ 
690 |a Nrf2 
690 |a Mitochondrial ROS 
690 |a Brain microvascular endothelial cells 
690 |a Diabetes 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 145, Iss 1, Pp 105-114 (2021) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861320301055 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/25c25d24eb614c8082e1f05f6b0251ad  |z Connect to this object online.